Entries by mercuric

Two events in Germany for Patient Advocates and Experts

ESMO Workshop: Science for Advocates Munich – 13 – 15 October 2017 Click here to apply and for further details. Travel grants available in limited number. ‘Science for advocates’ will be a 2-day interactive workshop (Friday afternoon till Sunday lunch-time) with a combination of lectures, independent and group work. To ensure effective communication, the workshop […]

EUPATI’s Latest News

EUPATI as an EPF programme is approaching the end of its first year, and EPF President Marco Greco evaluates the achievements – and challenges – of this new environment and shares his perspectives here. The EUPATI Training Course Patient Experts in Medicines Research & Development has 57 new participants in cohort three. This exciting and unique […]

EUPATI Webinar on Patient Experience in HTA | 26 September 2017, 17:00 to 18:30 CET

Join EUPATI‘s webinar to hear about patients relating their experience when going through Health Technology Assessment (HTA) processes. Two EUPATI Fellows, Paola Kruger (Italy) and Joan Jordan (Ireland) will share their experiences. The point of view of the pharmaceutical industry involved in the HTA process will also be highlighted. Two representatives from Roche, David McCarthy and […]

Hajrah A. Khawaja, QUB will present MErCuRIC research at ESMO in Madrid, September 2017

Hajrah A. Khawaja, a post-graduate student in the School of Medicine, Dentistry and Biomedical Sciences, Centre for Cancer Research and Cell Biology, at Queen’s University of Belfast, UK presents her poster ‘RalB GTPase: A potential novel target for RAS mutant colorectal cancer‘ at the European Society for Medical Oncology conference. ESMO 2017 will be held […]

New publication from UNITO

The UNITO team (D. Oddo et al.) has just published Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer in the British Journal of Cancer (DOI: 10.1038/bjc.2017.196). Background: Combined MET and BRAF inhibition showed clinical benefit in a patient with rectal cancer carrying BRAFV600E and MET amplification. However, after 4 months, acquired […]

New MErCuRIC Publication

MErCuRIC researchers have recently published a review in Nature Reviews Clinical Oncology. Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges Conor A. Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, Alberto Bardelli, Christian Rolfo, Josep Tabernero, Hajrah A. Khawaja, Mark Lawler, Patrick G. Johnston, Sandra Van Schaeybroeck & on behalf of the MErCuRIC consortium Data from many preclinical studies, including those using cellular models of colorectal, gastric, gastro-oesophageal and […]

Cancer Core Europe Summer School

Initiated in 2011 by the EurocanPlatform and since 2016 organized under the umbrella of Cancer Core Europe, the Summer School in Translational Cancer Research will once again take place in Portugal in Albufeira, 16 – 20 October, 2017. The registration deadline is 30 June 2017. You can learn more about the course here: https://dktk.dkfz.de/en/training/dktk-summer-school/introdution.  

EUPATI Expert Training Course

Applications are now being accepted for the third EUPATI Expert Training Course. The EUPATI Training Course Patient Experts in Medicines Research & Development is an exciting and unique opportunity offering patient advocates expert-level training in medicines research and development, specifically tailored for them. The application deadline is 31 March 2017.